利歐股份(002131.SZ):5名股東合計減持3726.76萬股 減持計劃實施完成
格隆匯6月18日丨利歐股份(002131.SZ)公佈,2021年6月18日,公司分別收到了張旭波先生(公司董事、副總經理)、陳林富先生(公司董事、財務總監)、黃卿文先生(原公司副總經理)、顏土富先生(公司副總經理)、鄭曉東先生(原公司董事、副總經理)的《關於股份減持計劃實施情況吿知函》,本次減持計劃已實施完成。
2020年12月22日-2021年6月18日,上述5名股東合計減持37,267,582股,佔總股本0.5518%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.